Article
BCL2 mutations in diffuse large B-cell lymphoma.
Leukemia - 1 Jun 2012
Schuetz J M, Johnson N A, Morin R D, Scott D W, Tan K, Ben-Nierah S, Boyle M, Slack G W, Marra M A, Connors J M, Brooks-Wilson A R, Gascoyne R D
Abstract excerpt
BCL2 is deregulated in diffuse large B-cell lymphoma (DLBCL) by the t(14;18) translocation, gene amplification and/or nuclear factor-κB signaling. RNA-seq data have recently shown that BCL2 is the most highly mutated gene in germinal center B-cell (GCB) DLBCL. We have sequenced BCL2 in 298 primary DLBCL biopsies, 131 additional non-Hodgkin lymphoma biopsies, 24 DLBCL cell lines and 51 germline DNAs. We found...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
